A 12-Month Prospective, Observational Study of Treatment Regimen and Quality of Life Associated With ADHD in Central and Eastern Europe and Eastern Asia (Q48786713)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 21, 2010

Language	Label	Description	Also known as
English	A 12-Month Prospective, Observational Study of Treatment Regimen and Quality of Life Associated With ADHD in Central and Eastern Europe and Eastern Asia	scientific article published on September 21, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

A 12-Month Prospective, Observational Study of Treatment Regimen and Quality of Life Associated With ADHD in Central and Eastern Europe and Eastern Asia (English)

1 reference

10.1177/1087054710381480

https://api.crossref.org/works/10.1177/1087054710381480

17 July 2024

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

object named as

Boong Nyun Kim

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

author name string

Michal Goetz

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

Chin-Bin Yeh

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

Igor Ondrejka

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

Aynur Akay

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

Ilona Herczeg

5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

Iuliana Dobrescu

6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

Xingming Jin

8

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

Ferenc Martényi

10

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

Gavan Harrison

11

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

Tamás Treuer

12

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

Boong Nyun Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20858785

17 July 2024

Anne W. Riley

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20858785

17 July 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20858785

17 July 2024

publication date

21 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

full work available at URL

http://journals.sagepub.com/doi/pdf/10.1177/1087054710381480

1 reference

10.1177/1087054710381480

https://api.crossref.org/works/10.1177/1087054710381480

17 July 2024

http://journals.sagepub.com/doi/full-xml/10.1177/1087054710381480

1 reference

10.1177/1087054710381480

https://api.crossref.org/works/10.1177/1087054710381480

17 July 2024

Journal of Attention Disorders

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

16

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

44-59

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

Medication prescribing practices in a child and adolescent psychiatry outpatient clinic

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic.

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Effect of gender and visit length on participation in pediatric visits.

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Effects of combined treatment on Turkish children diagnosed with attention-deficit/hyperactivity disorder: a preliminary report

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Epidemiology of attention problems among Turkish children and adolescents: a national study

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

The distribution of symptoms of attention-deficit/hyperactivity disorder and oppositional defiant disorder in school age children in Turkey.

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Worse quality of life for children with newly diagnosed attention-deficit/hyperactivity disorder, compared with asthmatic and healthy children.

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Analysis of treatment effectiveness in longitudinal observational data

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

A 3-year panel study of mental disorders among adolescents in Taiwan.

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Behavioral characteristics of DSM-IV ADHD subtypes in a school-based population.

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Validity of DSM-IVADHD subtypes in a nationally representative sample of Australian children and adolescents

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

The diagnosis and prevalence of hyperactivity in Chinese schoolboys

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Cross-cultural differences in rating hyperactive-disruptive behaviors in children

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Attention-deficit/hyperactivity disorder diagnosis, co-morbidities, treatment patterns, and quality of life in a pediatric population in central and eastern Europe and Asia

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Pharmacologic treatment of attention-deficit/hyperactivity disorder: efficacy, safety and mechanisms of action

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

The worldwide prevalence of ADHD: a systematic review and metaregression analysis

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD).

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

The Parent Report Form of the CHIP-Child Edition: reliability and validity.

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Factors related to health-related quality of life (HRQoL) among children with ADHD in Europe at entry into treatment

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Globalisation of international health

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Quality of life of adolescent males with attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F1087054710381480

21 January 2018

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

8

1 reference

10.1177/1087054710381480

https://api.crossref.org/works/10.1177/1087054710381480

17 July 2024

World Psychiatry

14

2

104

author name string

Faraone S. V.

publication date

2003

1 reference

10.1177/1087054710381480

https://api.crossref.org/works/10.1177/1087054710381480

17 July 2024

Comparison of attention-deficit/hyperactivity disorder symptom subtypes in Ukrainian schoolchildren

19

1 reference

10.1177/1087054710381480

https://api.crossref.org/works/10.1177/1087054710381480

17 July 2024

Turkish Journal of Pediatrics

27

50

160

author name string

Hirfanoğlu T.

publication date

2008

1 reference

10.1177/1087054710381480

https://api.crossref.org/works/10.1177/1087054710381480

17 July 2024

Teacher reports of DSM-IV ADHD, ODD, and CD symptoms in schoolchildren

32

1 reference

10.1177/1087054710381480

https://api.crossref.org/works/10.1177/1087054710381480

17 July 2024

Hyperactivity and comorbidity in Japanese children with attention-deficit/hyperactivity disorder

44

1 reference

10.1177/1087054710381480

https://api.crossref.org/works/10.1177/1087054710381480

17 July 2024

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

45

1 reference

10.1177/1087054710381480

https://api.crossref.org/works/10.1177/1087054710381480

17 July 2024

Identifiers

10.1177/1087054710381480

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/20858785

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48786713&oldid=2208106094"